Top Clinical Trials companies in India by Receivables

This ranking features the top 2 Clinical Trials companies in India ranked by Receivables, totaling a Receivables of USD 10.85 M, for January 31, 2025.

India

Clinical Trials
Receivables
#
Name
Receivables
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
VIMTALABS.NS

Vimta Labs Limited

1

VIMTALABS.NS
USD 10.43 M
March 31, 2024 USD 9.60 -2.28%

India
2
SUVEN.NS

Suven Life Sciences Limited

2

SUVEN.NS
USD 418.15 K
March 31, 2024 USD 1.34 1.98%

India
Frequently Asked Questions
  • Which Clinical Trials company in India has the highest Receivables ?

    The Clinical Trials company in India with the highest Receivables is Vimta Labs Limited (NSE: VIMTALABS.NS) at USD 10.43 M.

  • Which Clinical Trials company in India has the lowest Receivables ?

    The Clinical Trials company in India with the lowest Receivables is Suven Life Sciences Limited (NSE: SUVEN.NS) at USD 418.15 K.

SV Wall Street